What is the growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the market?

Key drivers include rising research activities and growing focus on safety testing in pharmaceutical industries.

What are the major challenges faced by the market?

Major challenges include ethical concerns, high maintenance costs, and stringent regulations.

Which regions are the leaders in the Non-human Primates in Research and Safety Testing market?

North America and Europe are the leading regions, accounting for over 60% of the market share.

Who are the top companies in the market?

Top companies include Charles River, Covance, and LabCorp, offering a range of research and testing services.

What are the future opportunities in the market?

Future opportunities include increasing adoption in emerging economies and growing demand for non-invasive testing methods.

How will technology impact the market?

Advances in technology, such as AI and genomics, will enhance research efficiency and accuracy, driving market growth.

What is the current regulatory landscape of the market?

The regulatory landscape is complex, with laws and guidelines varying by region, requiring companies to adapt to changing regulations.

What is the future outlook for the Non-human Primates in Research and Safety Testing market?

The future outlook is positive, with the market expected to reach USD 1.8 billion by 2033, driven by increasing research activities.

What Is the Global Non-human Primates in Research and Safety Testing Market Worth in 2026?

Non-human Primates in Research and Safety Testing by Application (Contract Research and Development Service Organization (CRO) Company, Scientific Research Institution, Colleges and Universities, Other), by Types (Macaca Fascicularis (Cynomolgus Macaque), Rhesus Monkey (Macaca Mulatta), Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 155

Forecast Period: 2026 - 2033

Market Size: $2644 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 155

Forecast Period: 2026 - 2033

Market Size: $2644 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Non-human Primates in Research and Safety Testing Market Overview

The Non-human Primates in Research and Safety Testing market refers to the use of non-human primates in laboratory settings for research and safety testing purposes. As the Non-human Primates in Research and Safety Testing market size is estimated to be around $1.2 billion, the growth outlook for this industry is expected to be significant, with a market forecast indicating a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033. The industry expansion is driven by factors such as increasing demand for non-human primates in biomedical research, growing focus on safety testing, and advancements in technology. The scope of this market includes the use of non-human primates in various applications such as biomedical research, safety testing, and toxicology testing.

Loading chart…

The current Non-human Primates in Research and Safety Testing market size is driven by factors such as increasing demand for non-human primates in biomedical research, growing focus on safety testing, and advancements in technology. The largest region for this market is North America, while the fastest-growing region is Asia-Pacific. Key forces shaping the industry include technology shifts such as the development of alternative methods, regulations such as the European Union's Directive 2010/63/EU, and competitive intensity among market players. As the market continues to evolve, it is expected to be driven by the growing demand for non-human primates in research and safety testing, with a growth forecast indicating a significant increase in the market size over the next few years.

Report Overview

Report Attribute	Details
Market size value in 2025	2.64 billion
Revenue forecast in 2033	4.61 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Vanny Bio Research; HZ-Bio; Envigo (Inotiv); JOINN LABORATORIES; WuXi AppTec; Jingang Biotech; Charles River; Pharmaron; Xishan Zhongke; ONPRC (Oregon National Primate Research Center); CNPRC (California National Primate Research Center); Sichuan Hengshu Bio-Technolog; Topgene Biotechnology; Primate Products, Inc. (PPI); Sichuan Green-House Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Non-human Primates in Research and Safety Testing market is experiencing significant fluctuations due to various factors. Understanding these dynamics is crucial for stakeholders to navigate the market effectively.

Growth Drivers2 items

Increasing demand for Non-human Primates in Research and Safety Testing in the pharmaceutical and biotechnology sectors, driven by the need for effective and safe drug development, is expected to boost the market size and growth forecast.

Advancements in genetic engineering and gene editing technologies, such as CRISPR, are expanding the applications of Non-human Primates in research, further driving the growth of the Non-human Primates in Research and Safety Testing market.

Restraints2 items

Stringent regulations and ethical concerns surrounding the use of Non-human Primates in research are limiting the market size and growth forecast, as some countries and organizations are moving towards alternative methods.

High maintenance and care costs associated with Non-human Primates are also restraining the market growth, as researchers and institutions are seeking more cost-effective options for research and safety testing.

Opportunities2 items

Emerging economies with less stringent regulations are presenting opportunities for the Non-human Primates in Research and Safety Testing market to expand, driven by government initiatives and investments in research infrastructure.

The growing demand for personalized medicine and targeted therapies is creating new opportunities for Non-human Primates in research, particularly in the areas of oncology and regenerative medicine, contributing to the growth forecast of the Non-human Primates in Research and Safety Testing market.

Challenges2 items

Ensuring the welfare and well-being of Non-human Primates used in research is a significant challenge, requiring specialized care and housing facilities, which can be a barrier to entry for new market participants in the Non-human Primates in Research and Safety Testing market.

The Non-human Primates in Research and Safety Testing market size and growth forecast are also influenced by public perception and awareness of animal research, which can impact funding and support for research initiatives, highlighting the need for effective communication and education strategies.

Market Segmentation

Loading chart…

The Application segment in the Non-human Primates in Research and Safety Testing market refers to the various uses of non-human primates in research and testing. This includes biomedical research, drug development, and safety testing. The application segment contributes significantly to the overall market size, with each subtype having a distinct impact. For instance, biomedical research accounts for a substantial share, driven by the use of non-human primates in studying diseases such as Alzheimer's and Parkinson's. Understanding the Non-human Primates in Research and Safety Testing segmentation is crucial for industry players to identify opportunities and trends in the market.

The Types segment in the Non-human Primates in Research and Safety Testing market encompasses various species of non-human primates used in research and testing. This includes Old World monkeys such as macaques and baboons, and New World monkeys such as capuchin and squirrel monkeys. Each type has its unique characteristics, making them suitable for specific research applications. The types segment is critical in determining the overall market size, as the demand for specific species can vary depending on research requirements. Analyzing the market taxonomy of non-human primates in research and safety testing helps in understanding the dynamics of the types segment and its contribution to the overall market.

Non-human Primates in Research and Safety Testing Segmentation Breakdown9 items

Application

Contract Research and Development Service Organization (CRO) Company

Scientific Research Institution

Colleges and Universities

Other

Types

Macaca Fascicularis (Cynomolgus Macaque)

Rhesus Monkey (Macaca Mulatta)

Others

Regional Insights

Loading chart…

The Non-human Primates in Research and Safety Testing market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing investments in research infrastructure and a growing demand for non-human primates in biomedical research.

Key drivers in North America include adoption of non-human primates in research, policies supporting animal research, and investments in research infrastructure. In Europe, drivers include ecosystem maturity, demographics of the research community, and infrastructure development. Asia Pacific's growth is driven by investments in research, policies supporting biomedical research, and a growing ecosystem of research institutions.

Latin America and Middle East & Africa are expected to experience moderate growth, driven by increasing adoption of non-human primates in research and growing investments in research infrastructure. The regional forecast indicates that Asia Pacific will drive the Non-human Primates in Research and Safety Testing market growth in the coming years, with a growing demand for non-human primates in biomedical research and increasing investments in research infrastructure.

Competitive Landscape

The Non-human Primates in Research and Safety Testing market is moderately consolidated, with a mix of global players and local/regional companies. The market is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Non-human Primates in Research and Safety Testing competitive landscape is characterized by high competition, with companies focusing on differentiation through innovative products and services. Global players are expanding their presence in emerging markets, while local companies are leveraging their regional expertise to compete with larger players.

Companies in this market are adopting various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To address these challenges, companies are focusing on strategic initiatives such as regional expansion, vertical integration, and innovation pipeline development.

Vanny Bio Research: regional expansion

HZ-Bio: vertical integration

Envigo (Inotiv): innovation pipeline

JOINN LABORATORIES: premium pricing

WuXi AppTec: OEM tie-ups

Jingang Biotech: local manufacturing

Key Non-human Primates in Research and Safety Testing Companies15 items

Vanny Bio Research

HZ-Bio

Envigo (Inotiv)

JOINN LABORATORIES

WuXi AppTec

Jingang Biotech

Charles River

Pharmaron

Xishan Zhongke

ONPRC (Oregon National Primate Research Center)

CNPRC (California National Primate Research Center)

Sichuan Hengshu Bio-Technolog

Topgene Biotechnology

Primate Products, Inc. (PPI)

Sichuan Green-House Biotech

Market Ecosystem

The Non-human Primates in Research and Safety Testing ecosystem spans upstream, midstream, and downstream activities, involving various participants who create and capture value. Upstream, technology providers and suppliers deliver essential components and services. Midstream, integrators and channels facilitate the development and distribution of research and testing solutions. Downstream, end users, such as pharmaceutical and biotechnology companies, utilize these solutions to conduct research and safety testing.

Raw material suppliers — provide non-human primates

Technology providers — develop research and testing tools

System integrators — design and implement research facilities

Distributors — supply research and testing equipment

Service providers — offer research and testing services

End users — conduct research and safety testing

Regulators — establish standards and guidelines

In the Non-human Primates in Research and Safety Testing ecosystem, value flows through the interactions among participants. Control points, such as regulatory bodies and large pharmaceutical companies, influence adoption and direction. Dependency risks, including input constraints, standards, and approvals, can impact the ecosystem's functioning. Switching costs, partnerships, and interoperability requirements also affect how participants interact. As the ecosystem differs by region, with varying standards and regulations, understanding these nuances is crucial for navigating the complex Non-human Primates in Research and Safety Testing ecosystem and conducting effective value chain analysis.

Recent Industry Insights

The Non-human Primates in Research and Safety Testing industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between leading research institutions and pharmaceutical companies have accelerated the discovery of new treatments and therapies. Additionally, mergers and acquisitions have led to the expansion of existing facilities and the establishment of new ones, enhancing the industry's capabilities. Product and technology launches have also improved the efficiency and accuracy of research and safety testing procedures.

Furthermore, regulatory changes have emphasized the need for more stringent safety protocols and ethical considerations in the use of non-human primates in research. Shifts in consumer and enterprise trends have also driven the demand for alternative testing methods, such as in vitro and computer simulations. Funding rounds and expansions have supported the growth of the industry, enabling companies to invest in innovative technologies and skilled personnel. These developments are expected to shape the future of the Non-human Primates in Research and Safety Testing industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Non-human Primates in Research and Safety Testing market outlook. The market attractiveness is moderate, driven by the increasing demand for non-human primates in biomedical research and safety testing. However, the competitive intensity is high due to the limited number of suppliers and the stringent regulations governing the use of non-human primates.

The long-term outlook for the market is promising, with a growing need for non-human primates in emerging fields such as gene therapy and regenerative medicine. The innovation landscape is evolving, with advancements in in vitro models and alternative testing methods. Despite this, the demand-supply balance remains a concern, with a shortage of non-human primates in some regions. Key risk factors include regulatory changes, public opinion, and the spread of diseases among non-human primate populations.

12 items

1. Executive Summary

2. Non-human Primates in Research and Safety Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-human Primates in Research and Safety Testing Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Non-human Primates in Research and Safety Testing Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Non-human Primates in Research and Safety Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Non-human Primates in Research and Safety Testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Non-human Primates in Research and Safety Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Non-human Primates in Research and Safety Testing Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Non-human Primates in Research and Safety Testing Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Non-human Primates in Research and Safety Testing Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Non-human Primates in Research and Safety Testing Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Non-human Primates in Research and Safety Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-human Primates in Research and Safety Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Non-human Primates in Research and Safety Testing Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Non-human Primates in Research and Safety Testing Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Non-human Primates in Research and Safety Testing Market Competition by Key Manufacturers

9.1. Global Non-human Primates in Research and Safety Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Non-human Primates in Research and Safety Testing: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Vanny Bio Research

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. HZ-Bio

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Envigo (Inotiv)

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. JOINN LABORATORIES

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. WuXi AppTec

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Jingang Biotech

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Charles River

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Pharmaron

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Xishan Zhongke

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. ONPRC (Oregon National Primate Research Center)

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. CNPRC (California National Primate Research Center)

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Sichuan Hengshu Bio-Technolog

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Topgene Biotechnology

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Primate Products, Inc. (PPI)

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Sichuan Green-House Biotech

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-human Primates in Research and Safety Testing Market

Figure 4: Global Non-human Primates in Research and Safety Testing Market: Drivers

Figure 5: Global Non-human Primates in Research and Safety Testing Market: Challenges

Figure 6: Global Non-human Primates in Research and Safety Testing Market: Trends

Figure 7: Global Non-human Primates in Research and Safety Testing Market: Opportunity

Figure 8: Global Non-human Primates in Research and Safety Testing Market: Restraint

Figure 9: Global Non-human Primates in Research and Safety Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Non-human Primates in Research and Safety Testing Market Value (USD Million) By Region

Figure 19: Global Non-human Primates in Research and Safety Testing Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Non-human Primates in Research and Safety Testing Market Value (USD Million) By Region

Figure 27: Global Non-human Primates in Research and Safety Testing Market Share (%) By: Regions (2032)

Figure 28: Global Non-human Primates in Research and Safety Testing Market Volume (K) By Region

Figure 29: Global Non-human Primates in Research and Safety Testing Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Non-human Primates in Research and Safety Testing Market Value (USD Million) By Region

Figure 37: Global Non-human Primates in Research and Safety Testing Market Share (%) By: Regions (2032)

Figure 38: Global Non-human Primates in Research and Safety Testing Market Volume (K) By Region

Figure 39: Global Non-human Primates in Research and Safety Testing Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-human Primates in Research and Safety Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Non-human Primates in Research and Safety Testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Non-human Primates in Research and Safety Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Non-human Primates in Research and Safety Testing Market Value (USD Million) By Region

Table 14: Global Non-human Primates in Research and Safety Testing Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Non-human Primates in Research and Safety Testing Market Volume (K) By Region

Table 31: Global Non-human Primates in Research and Safety Testing Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Non-human Primates in Research and Safety Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Non-human Primates in Research and Safety Testing Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Non-human Primates in Research and Safety Testing Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Vanny Bio Research Basic Information And Sales Area

Table 52: Vanny Bio Research. Products Portfolio

Table 53: HZ-Bio Basic Information And Sales Area

Table 54: HZ-Bio. Products Portfolio

Table 55: Envigo (Inotiv) Basic Information And Sales Area

Table 56: Envigo (Inotiv). Products Portfolio

Table 57: JOINN LABORATORIES Basic Information And Sales Area

Table 58: JOINN LABORATORIES. Products Portfolio

Table 59: WuXi AppTec Basic Information And Sales Area

Table 60: WuXi AppTec. Products Portfolio

Table 61: Jingang Biotech Basic Information And Sales Area

Table 62: Jingang Biotech. Products Portfolio

Table 63: Charles River Basic Information And Sales Area

Table 64: Charles River. Products Portfolio

Table 65: Pharmaron Basic Information And Sales Area

Table 66: Pharmaron. Products Portfolio

Table 67: Xishan Zhongke Basic Information And Sales Area

Table 68: Xishan Zhongke. Products Portfolio

Table 69: ONPRC (Oregon National Primate Research Center) Basic Information And Sales Area

Table 70: ONPRC (Oregon National Primate Research Center). Products Portfolio

Table 71: CNPRC (California National Primate Research Center) Basic Information And Sales Area

Table 72: CNPRC (California National Primate Research Center). Products Portfolio

Table 73: Sichuan Hengshu Bio-Technolog Basic Information And Sales Area

Table 74: Sichuan Hengshu Bio-Technolog. Products Portfolio

Table 75: Topgene Biotechnology Basic Information And Sales Area

Table 76: Topgene Biotechnology. Products Portfolio

Table 77: Primate Products, Inc. (PPI) Basic Information And Sales Area

Table 78: Primate Products, Inc. (PPI). Products Portfolio

Table 79: Sichuan Green-House Biotech Basic Information And Sales Area

Table 80: Sichuan Green-House Biotech. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Non-human Primates in Research and Safety Testing Market Value (USD Million) By Region

Table 90: Global Non-human Primates in Research and Safety Testing Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Application

Table 93: North America Market Value (USD Million) (2025-2032) By Types

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Types

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Types

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 106: Global Non-human Primates in Research and Safety Testing Market Volume (K) By Region

Table 107: Global Non-human Primates in Research and Safety Testing Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Application

Table 110: North America Market Volume (K) (2025-2032) By Types

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Types

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Types

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Non-human Primates in Research and Safety Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.64 billion
Revenue forecast in 2033	4.61 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Vanny Bio Research; HZ-Bio; Envigo (Inotiv); JOINN LABORATORIES; WuXi AppTec; Jingang Biotech; Charles River; Pharmaron; Xishan Zhongke; ONPRC (Oregon National Primate Research Center); CNPRC (California National Primate Research Center); Sichuan Hengshu Bio-Technolog; Topgene Biotechnology; Primate Products, Inc. (PPI); Sichuan Green-House Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Non-human Primates in Research and Safety Testing Segmentation Breakdown9 items

Application

Contract Research and Development Service Organization (CRO) Company

Scientific Research Institution

Colleges and Universities

Other

Types

Macaca Fascicularis (Cynomolgus Macaque)

Rhesus Monkey (Macaca Mulatta)

Others

Regional Insights

Loading chart…

Competitive Landscape

Vanny Bio Research: regional expansion

HZ-Bio: vertical integration

Envigo (Inotiv): innovation pipeline

JOINN LABORATORIES: premium pricing

WuXi AppTec: OEM tie-ups

Jingang Biotech: local manufacturing

Key Non-human Primates in Research and Safety Testing Companies15 items

Vanny Bio Research

HZ-Bio

Envigo (Inotiv)

JOINN LABORATORIES

WuXi AppTec

Jingang Biotech

Charles River

Pharmaron

Xishan Zhongke

ONPRC (Oregon National Primate Research Center)

CNPRC (California National Primate Research Center)

Sichuan Hengshu Bio-Technolog

Topgene Biotechnology

Primate Products, Inc. (PPI)

Sichuan Green-House Biotech

Market Ecosystem

Raw material suppliers — provide non-human primates

Technology providers — develop research and testing tools

System integrators — design and implement research facilities

Distributors — supply research and testing equipment

Service providers — offer research and testing services

End users — conduct research and safety testing

Regulators — establish standards and guidelines

Recent Industry Insights

Analyst Overview

Table of Contents